Differential Presentations, Clinical Courses, and Survivals of Osteosarcomas of the Proximal Humerus over Other Extremity Locations

被引:54
作者
Cho, Wan Hyeong [1 ]
Song, Won Seok [1 ]
Jeon, Dae-Geun [1 ]
Kong, Chang-Bae [1 ]
Kim, Min Suk [2 ]
Lee, Jun Ah [3 ]
Yoo, Ji Young [4 ]
Do Kim, Jae [5 ]
Lee, Soo-Yong [1 ]
机构
[1] Korea Canc Ctr Hosp, Dept Orthoped Surg, Seoul, South Korea
[2] Korea Canc Ctr Hosp, Dept Pathol, Seoul, South Korea
[3] Korea Canc Ctr Hosp, Dept Pediat, Seoul, South Korea
[4] Korea Canc Ctr Hosp, Dept Radiol, Seoul, South Korea
[5] Kosin Univ, Sch Med, Dept Orthoped Surg, Pusan, South Korea
关键词
TUMOR VOLUME CHANGE; NEOADJUVANT CHEMOTHERAPY; PROGNOSTIC-FACTORS; PATHOLOGICAL FRACTURE; LOCALIZED OSTEOSARCOMA; EXPERIENCE; SARCOMA; RECURRENCE; PREDICTOR; INSTITUTE;
D O I
10.1245/s10434-009-0825-6
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although there are controversies about the prognosis of proximal humeral osteosarcoma, our previous study showed poor survival in those patients. In the present study, we undertook to determine why this site is associated with a poor outcome and to identify the clinicopathologic variables involved. The study cohort consisted of 36 proximal humeral and 341 other extremity American Joint Committee on Cancer (AJCC) stage II osteosarcomas. We examined the clinicopathologic differences between these osteosarcomas. The prognostic significances of factors identified for a proximal humoral location were evaluated by survival analysis of all 377 patients. Patients with a proximal humeral osteosarcoma had the following characteristics: a higher incidence of pathologic fracture (P < 0.01), an osteolytic pattern on plain radiographs (P < 0.01), an unusual pathological subtype (P = 0.01), poor histologic response (P < 0.01), and an increased tumor-volume ratio (TVR) (P < 0.01). Multivariate analysis revealed that a large tumor volume (P < 0.01), an increase in tumor volume (P < 0.01), and a poor histologic response to preoperative chemotherapy (P < 0.01) independently predicted shorter metastasis-free survival. The association between proximal humeral osteosarcoma and poor survival could be the result of unresponsiveness to chemotherapy, which was expressed by a tumor volume increase in our patients.
引用
收藏
页码:702 / 708
页数:7
相关论文
共 29 条
[1]   Nonmetastatic osteosarcoma of the extremity with pathologic fracture at presentation - Local and systemic control by amputation or limb salvage after preoperative chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Longhi, A ;
Donati, D ;
Manfrini, M ;
Giacomini, S ;
Briccoli, A ;
Forni, C ;
Galletti, S .
ACTA ORTHOPAEDICA SCANDINAVICA, 2003, 74 (04) :449-454
[2]   Predictive factors for local recurrence in osteosarcoma - 540 patients with extremity tumors followed for minimum 2.5 years after neoadjuvant chemotherapy [J].
Bacci, G ;
Ferrari, S ;
Mercuri, M ;
Bertoni, F ;
Picci, P ;
Manfrini, M ;
Gasbarrini, A ;
Forni, C ;
Cesari, M ;
Campanacci, M .
ACTA ORTHOPAEDICA SCANDINAVICA, 1998, 69 (03) :230-236
[3]   Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy - 15-year experience in 789 patients treated at a single institution [J].
Bacci, G ;
Longhi, A ;
Versari, M ;
Mercuri, M ;
Briccoli, A ;
Picci, P .
CANCER, 2006, 106 (05) :1154-1161
[4]   Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: Experience at rizzoli on 1421 patients treated over the last 30 years [J].
Bacci, G ;
Longhi, A ;
Ferrari, S ;
Briccoll, A ;
Donati, D ;
De Paolis, M ;
Versari, M .
TUMORI, 2004, 90 (05) :478-484
[5]  
Bacci G, 2002, ONCOL REP, V9, P171
[6]   Prognostic factors in high-grade osteosarcoma of the extremities or trunk:: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols [J].
Bielack, SS ;
Kempf-Bielack, B ;
Delling, G ;
Exner, GU ;
Flege, S ;
Helmke, K ;
Kotz, R ;
Salzer-Kuntschik, M ;
Werner, M ;
Winkelmann, W ;
Zoubek, A ;
Jürgens, H ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (03) :776-790
[7]   Tumor size and prognosis in aggressively treated osteosarcoma [J].
Bieling, P ;
Rehan, N ;
Winkler, P ;
Helmke, K ;
Maas, R ;
Fuchs, N ;
Bielack, S ;
Heise, U ;
Jurgens, H ;
Treuner, J ;
Romanowski, R ;
Exner, U ;
Kotz, R ;
Winkler, K .
JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (03) :848-858
[8]  
Bramer J A., 2009, Eur J Surg Oncol
[9]   Do pathological fractures influence survival and local recurrence rate in bony sarcomas? [J].
Bramer, J. A. M. ;
Abudu, A. A. ;
Grimer, R. J. ;
Carter, S. R. ;
Tillman, R. M. .
EUROPEAN JOURNAL OF CANCER, 2007, 43 (13) :1944-1951
[10]  
Carsi B, 2002, CLIN ORTHOP RELAT R, P53